Navigation Links
Circassia Raises GBP15 Million ($25 Million) in Oversubscribed Investment Round
Date:12/11/2009

OXFORD, England, December 11 /PRNewswire/ --

- Investment Follows Successful Phase Ii Clinical Results With cat Allergy T-cell Vaccine

- Funding to Progress ToleroMune(R) T-cell Allergy Vaccines Into Late-Stage Development

Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that it has completed a GBP15 million ($25 million) fundraising. The investment round, which was led by Imperial Innovations and supported by existing shareholders including Invesco Perpetual and Lansdowne Partners, was significantly oversubscribed and is the company's third successful fundraising. The investment follows recently announced positive phase II results with Circassia's ToleroMune(R) cat allergy T-cell vaccine. The financing will support the acceleration of the programme into late-stage development and advance the clinical development of Circassia's broader portfolio of novel allergy T-cell vaccines.

"The success of this funding round is a great vote of confidence in Circassia's unique allergy T-cell vaccine technology and the dedication of our team," said Steve Harris, Circassia's CEO. "Our most recent clinical results clearly demonstrate the potential of our ToleroMune(R) technology, as well as scientifically validating our novel use of T-cell vaccines to improve the treatment of allergy sufferers. This new investment recognises the importance of these results, and represents a strategic milestone in the development of Circassia's next generation allergy treatments."

About Circassia's allergy T-cell vaccines

Circassia's range of allergy T-cell vaccines is based on its proprietary ToleroMune(R) technology. This technology utilises allergen epitopes to generate regulatory T cells that suppress allergic immune responses. Clinical results with Circassia's cat allergy T-cell vaccine show that short treatment regimes can greatly reduce pat
'/>"/>

SOURCE Circassia Ltd
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Circassia Begins Phase II Clinical Trial With Ragweed Allergy Therapy
2. Circassias Allergy Therapy Begins Phase II Clinical Trial in Asthma Patients
3. Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment
4. Circassia Initiates Further Phase II Clinical Study of Toleromune(R) Anti-Allergy Technology
5. Circassia Achieves Successful Phase II Clinical Results With Toleromune(R) Anti-Allergy Technology
6. Apnex Medical, Inc. Raises Additional $14 Million
7. Cambridge-based Ligon Discovery Raises $1M in Seed Funding
8. FREE Drug Discount Card Saves Money on Prescriptions and Raises Funds for Americas Disabled Veterans
9. CareFusion Reports First Quarter Results, Raises Full-Year Outlook
10. NxStage(R) Reports Third Quarter 2009 Financial Results and Raises Revenue Guidance for Fiscal 2009
11. Cancer Diagnostics Company, On-Q-ity, Raises $21M in Series A Funding for the Development of Technologies to Personalize Cancer Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 14, 2014 /PRNewswire-iReach/ -- Acumed,s new SLIC Screw System ... accompanying instrumentation to place and insert the screw accurately ... tissue (e.g. ligament) repair or reconstruction as it holds ... (Photo: http://photos.prnewswire.com/prnh/20140114/MN45636 ) The ...
(Date:1/14/2014)... NuAire , a manufacturer of ergonomically designed laboratory equipment ... of Japan to sell and service the ... NuAire will utilize its network of sales professionals throughout ... to offer assistance in application use, product benefits and features, options ...
(Date:1/14/2014)... VALHALLA, N.Y. , Jan. 14, 2014   Oligomerix, Inc. ... disease modifying therapeutics for Alzheimer,s disease (AD) and related ... headquarters to Valhalla, NY as ... additional laboratory space at New York Medical College. ...
Breaking Medicine Technology:Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 2Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 3NuAire announces sales and service of Hitachi Koki centrifuges in North America 2Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2
... Texas, May 22, 2012  Prodigy Generics, a division of ... Irinotecan is the generic equivalent of the branded drug ... Pharmaceutical Laboratories to develop a portfolio of oncology products. ... through the partnership that will add consistent supply and ...
... May 22, 2012  MusclePharm Corporation (OTCBB: MSLP.OB), a nutritional ... it has signed Major League Baseball phenom Bryce Harper ... disclosed. Harper, a 19-year-old star outfielder for ... April 28.  He previously was the Number 1 overall ...
Cached Medicine Technology:MusclePharm Signs Pro Baseball Rookie Phenom Bryce Harper As Sponsored Athlete 2
(Date:4/17/2014)... of Medicine (BUSM) have discovered that the anti-seizure ... model. The findings, reported in the American ... lead to more effective treatments for alcoholism. , ... leading causes of illness and death in the ... limiting the productivity of workers and necessitating huge ...
(Date:4/17/2014)... by researchers at UC Davis has shown that the ... in cell division, also boosts the mitochondrial activity to ... complex has been shown to perform both jobs. This ... to control cellular energy production, potentially advancing cancer care ... in the journal Developmental Cell . , "These ...
(Date:4/17/2014)... by Cesar A. Arias, M.D., Ph.D., at The University ... identified a new superbug that caused a bloodstream infection ... April 17 issue of The New England Journal ... of a class of highly-resistant bacteria known as methicillin-resistant ... major cause of hospital and community-associated infections. The superbug ...
(Date:4/17/2014)... days to find a colored ribbon representing a disease. A ... what color ribbon does one think of with lung cancer?, ... many suffering from the disease, black may be the only ... of lung cancer patients, primarily smokers between the ages of ... the stigma often felt by these patients, the emotional toll ...
(Date:4/17/2014)... alleviates muscle soreness after exercise, according to a ... at Chicago. , The study, reported online in ... Physical Medicine and Rehabilitation , also showed that ... not exercised, suggesting that massage has benefits for ... , Improved circulation and relief of muscle soreness ...
Breaking Medicine News(10 mins):Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2Health News:Dual role: Key cell division proteins also power up mitochondria 2Health News:New MRSA superbug emerges in Brazil 2Health News:Unraveling the 'black ribbon' around lung cancer 2Health News:Massage therapy improves circulation, eases muscle soreness 2
... Jan. 23, 2009 -- In recent years, genetic studies ... diseases, such as cancer or diabetes, raising the prospect ... in an individual,s genome. ,But the variations identified to ... one to three percent of the overall genetic ...
... PRINCETON, N.J., Jan. 22 Novo Nordisk, a global healthcare ... FORTUNE ,s 2009 "100 Best Companies to Work For" awards ... received this prestigious award -- one of the most influential ... Companies to Work For" are historically good performers in the ...
... may be the cause, experts say , , THURSDAY, Jan. 22 ... United States are dying at twice the rate they were ... to blame. , The report, led by the U.S. Geological ... included trees in a variety of forests, elevations and sizes. ...
... the 40 million American adults who suffer from anxiety disorders ... children are diagnosed with anxiety, Tel Aviv University researchers have ... assessed at an early age and that something can ... Dr. Orit Bart at Tel Aviv University,s School of Health ...
... in First Seven Weeks on Jenny Craig*CARLSBAD, Calif., Jan. ... leading authorities on weight management, hosted a press conference ... the newest Jenny Craig celebrity client and spokesperson. The ... is looking forward to sharing her journey in hopes ...
... Travel Advantage Network , one of the nation,s ... Susan G. Komen for the Cure , the global leader ... pin sales and a Jeans Day, where employees purchase the ... employees raised $729 for Susan G. Komen for the Cure, ...
Cached Medicine News:Health News:Genetic interactions are the key to understanding complex traits 2Health News:Genetic interactions are the key to understanding complex traits 3Health News:Novo Nordisk Makes its Debut in FORTUNE's '100 Best Companies to Work For' 2Health News:Novo Nordisk Makes its Debut in FORTUNE's '100 Best Companies to Work For' 3Health News:Old-Growth Forests Dying Off in U.S. West 2Health News:Old-Growth Forests Dying Off in U.S. West 3Health News:Mind out of balance, body out of balance 2Health News:Phylicia Rashad Selected as New Spokesperson for Jenny Craig 2Health News:Grassroots Group Gets Travel Advantage Network Support 2
Platinum General Purpose Cautery Electrodes , ,A - Loop Tip, ,Fully autoclavable. Tips typically last for 50 to 100 or more procedures, depending on burn time....
Non-Cantilevered, "Teardrop" Ringed Forceps. ("fixation clamp") For vasectomy and other procedures. Ring ovoid approximately 6.0 mm in diameter....
... Customized stethoscope earmolds add comfort and ... such as ambulance paramedics, Flight-for-Life helicopter personnel, ... ,These molds are specific in design and ... any stethoscope used in today's industry to ...
... Bispectral Index (BIS®) measurement uses Aspect Medical ... of consciousness and sedation monitoring for use ... settings., ,The plug-and-play BISx Power Link™ ... integrated clamp for quick and easy mounting ...
Medicine Products: